The investment in SAP® is one of many improvements to the company’s business processes that have been implemented over the last year as the new management team focuses on building a solid platform for growth
Milford, MA (PRWEB) August 08, 2013
SeraCare Life Sciences, a provider of high quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, completed its implementation of SAP® enterprise resource planning (ERP) software. The SAP® system integrates the company’s inventory planning and control, purchasing, production management, quality management and financial reporting systems into a single software solution.
“Our deployment of SAP® delivers greater insight into day-to-day processes and facilitates data-driven forecasting and planning,” said Charles Mamrak, CEO of SeraCare. “SAP will enable us to better meet customer needs with faster, more accurate information about product availability, product specifications, order tracking, and more.”
The investment in SAP® is one of many improvements to the company’s business processes that have been implemented over the last year as the new management team focuses on building a solid platform for growth as a leader in life science tools focused on the diagnostic market. At the beginning of this year, SeraCare reorganized into three market-focused business units serving diagnostic company researchers, manufacturers and clinical laboratories. These fully staffed business units bring focused products and a wealth of experience spanning the diagnostic product development cycle from concept to clinic. The enhanced software systems will provide an even better customer experience going forward.
About SeraCare Life Sciences, Inc.
SeraCare, a portfolio company of Linden Capital Partners, works with diagnostics researchers, IVD manufacturers and clinical laboratories to shape the future of medical diagnostics. Our innovative portfolio includes ACCURUN® quality controls, AccuTrak™, AccuSpan™, AccuSet™ and AccuVert™ panels, SeraCon™ processed plasma, specialty human blood products and Complete BioCollections™ materials. SeraCare helps bridge the gap between today’s diagnostic solutions and tomorrow’s emerging technologies for molecular diagnostics, next generation sequencing, and companion diagnostics. For more information, visit http://www.seracare.com/.
About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life science industries. Linden's strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden currently has investments in middle market platforms in the products, distribution, and services segments of healthcare. For additional information about Linden, please refer to the firm's website at http://www.lindenllc.com.